A Pilot Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multicenter Trial to Evaluate the Effect of Ranitidine on Immunologic Indicators in Asymptomatic HIV-1 Infected Subjects With a CD4 Cell Count Between 400-700 Cells/mm3

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00002106

Recruitment Status : Completed

First Posted : August 31, 2001

Last Update Posted : June 24, 2005

View this study on Beta.ClinicalTrials.gov

Sponsor:

Information provided by:

NIH AIDS Clinical Trials Information Service

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Primary Completion Date :	No date given
Study Completion Date :	No date given

Publications:

Bartlett JA, Berry PS, Bockman KW, Stein A, Johnson J, Graham S, Quinn J, DeMasi R, Alexander WJ. A placebo-controlled trial of ranitidine in patients with early human immunodeficiency virus infection. J Infect Dis. 1998 Jan;177(1):231-4. doi: 10.1086/517361.

To Top